A Virtual Reality View—New Biologics and the Evolution of Psoriasis Treatment: Improving Patient Outcomes and Quality of Life with Targeted Therapy

View Activity

FACULTY

Junko Takeshita, MD, PhD
Assistant Professor of Dermatology and Epidemiology
Department of Dermatology
Department of Biostatistics and Epidemiology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA

PROGRAM OVERVIEW

This online activity is focused on the care of patients with psoriasis. We aim to help learners review recent discoveries in psoriasis pathophysiology; discuss the mechanisms, efficacy, and safety of new and emerging biologics; review
symptoms, quality of life, and therapeutic goals for optimal psoriasis management; and evaluate the relationship
between psoriasis and cardiovascular disease.

TARGET AUDIENCE

This activity is intended for dermatologists and other healthcare professionals involved in the management of patients
with psoriasis.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Explain how recent discoveries in psoriasis pathophysiology have informed on potential therapeutic targets.
  • Describe the relationship between psoriasis and CVD and best practices for screening and management of CVD
    in patients with psoriasis.
  • Discuss mechanisms of action and efficacy/safety profiles of new and emerging biologics for patients with
    moderate-to-severe psoriasis.
  • Review assessments of response kinetics, symptoms, quality of life, and overall therapeutic goals in patients
    with psoriasis, based on approved and investigational targeted biologics.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with psoriasis.

Credits: 1.0 ANCC Contact Hours

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial
Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence,
objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the
manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an
educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Takeshita has received a research grant (to the Trustees of the University of Pennsylvania) from Pfizer Inc. and
received payment for CME work related to psoriasis that was supported indirectly by Eli Lilly and Novartis.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices
they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Senior Program Manager for Med Learning Group, has nothing to disclose.
Chris Drury, MA, MS, Medical and Scientific Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any
unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-
approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certification via email within 30 days.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The
participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITY ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning
Group prior to the event at info@medlearninggroup.com.

RELEASE DATE: June 14, 2018

EXPIRATION DATE: June 14, 2019

View Activity

Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.